Abstract
The results of an investigation show that there is no statistically significant excess of blood group A in cases of carcinoma of the oesophagus or in cases of benign prostatic hyperplasia.
Full text
PDF![42](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/162b/480668/14e41d76f5ce/jclinpath00078-0046.png)
![43](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/162b/480668/f8c262ebeea5/jclinpath00078-0047.png)
![44](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/162b/480668/04c073c30239/jclinpath00078-0048.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AIRD I., LEE D. R., ROBERTS J. A. ABO blood groups and cancer of oesophagus, cancerof pancreas, and pituitary adenoma. Br Med J. 1960 Apr 16;1(5180):1163–1166. doi: 10.1136/bmj.1.5180.1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BEASLEY W. H. Blood groups of gastric ulcer and carcinoma. Br Med J. 1960 Apr 16;1(5180):1167–1172. doi: 10.1136/bmj.1.5180.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BILLINGTON B. P. A note on ABO blood group distribution in carcinoma of the oesophagus and cardia. Australas Ann Med. 1957 Feb;6(1):56–57. doi: 10.1111/imj.1957.6.1.56. [DOI] [PubMed] [Google Scholar]
- BOURKE J. B., GRIFFIN J. P. Blood-groups in benign and malignant prostatic hypertrophy. Lancet. 1962 Dec 15;2(7268):1279–1280. doi: 10.1016/s0140-6736(62)92855-6. [DOI] [PubMed] [Google Scholar]
- CASE J., RAEBURN C., WALTHER W. W. Blood-groups in relation to malignant diseases. Lancet. 1956 Nov 10;271(6950):970–972. doi: 10.1016/s0140-6736(56)90324-5. [DOI] [PubMed] [Google Scholar]
- PROSSER I. [ABO blood groups in hypertrophy of the prostate]. Minerva Urol. 1959 Nov-Dec;11:253–255. [PubMed] [Google Scholar]
- WOOLF B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955 Jun;19(4):251–253. doi: 10.1111/j.1469-1809.1955.tb01348.x. [DOI] [PubMed] [Google Scholar]